Literature DB >> 19441930

Apigenin and related compounds stimulate adult neurogenesis. Mars, Inc., the Salk Institute for Biological Studies: WO2008147483.

Philippe Taupin1.   

Abstract

The application is in the field of adult neurogenesis and its therapeutic potential. It aims to characterize the activity of apigenin and related compounds on adult neurogenesis in vivo and in vitro. Apigenin and related compounds are derivatives used in food products. They were administered intraperitoneally and orally in adult rodents and assessed for their activity in promoting the generation of neuronal cells and learning and memory performance. They were also tested on adult rat hippocampal-derived neural progenitor and stem cells to assess their neurogenic property. Apigenin and related compounds stimulate adult neurogenesis in vivo and in vitro, by promoting neuronal differentiation. Apigenin promotes learning and memory performance in the Morris water task. The application claims the use of apigenin and related compounds for stimulating adult neurogenesis and for the treatment of neurological diseases, disorders and injuries, by stimulating the generation of neuronal cells in the adult brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19441930     DOI: 10.1517/13543770902721279

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  16 in total

1.  Neuroprotective activity of hydroponic Teucrium polium following bilateral ovariectomy.

Authors:  K V Simonyan; V A Chavushyan
Journal:  Metab Brain Dis       Date:  2014-12-13       Impact factor: 3.584

2.  Apium graveolens extract influences mood and cognition in healthy mice.

Authors:  Phetcharat Boonruamkaew; Wanida Sukketsiri; Pharkphoom Panichayupakaranant; Wijittra Kaewnam; Supita Tanasawet; Varomyalin Tipmanee; Pilaiwanwadee Hutamekalin; Pennapa Chonpathompikunlert
Journal:  J Nat Med       Date:  2017-02-15       Impact factor: 2.343

3.  Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.

Authors:  Faycal Guedj; Ashley E Siegel; Jeroen L A Pennings; Fatimah Alsebaa; Lauren J Massingham; Umadevi Tantravahi; Diana W Bianchi
Journal:  Am J Hum Genet       Date:  2020-10-23       Impact factor: 11.025

4.  Apigenin induces dermal collagen synthesis via smad2/3 signaling pathway.

Authors:  Y Zhang; J Wang; X Cheng; B Yi; X Zhang; Q Li
Journal:  Eur J Histochem       Date:  2015-04-13       Impact factor: 3.188

5.  Molecular docking of selected phytocompounds with H1N1 Proteins.

Authors:  Mohammed I Alhazmi
Journal:  Bioinformation       Date:  2015-04-30

6.  Apigenin Ameliorates Post-Stroke Cognitive Deficits in Rats Through Histone Acetylation-Mediated Neurochemical Alterations.

Authors:  Fengxia Tu; Qiongyi Pang; Tingting Huang; Yun Zhao; Meixia Liu; Xiang Chen
Journal:  Med Sci Monit       Date:  2017-08-19

7.  Taurine induces proliferation of neural stem cells and synapse development in the developing mouse brain.

Authors:  Mattu Chetana Shivaraj; Guillaume Marcy; Guoliang Low; Jae Ryun Ryu; Xianfeng Zhao; Francisco J Rosales; Eyleen L K Goh
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

8.  Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

Authors:  Anne Corbett; Gareth Williams; Clive Ballard
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-11

9.  Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease.

Authors:  Galba Jean Beppe; Alain Bertrand Dongmo; Harquin Simplice Foyet; Nolé Tsabang; Zenovia Olteanu; Oana Cioanca; Monica Hancianu; Théophile Dimo; Lucian Hritcu
Journal:  BMC Complement Altern Med       Date:  2014-04-30       Impact factor: 3.659

10.  The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice.

Authors:  Pennapa Chonpathompikunlert; Phetcharat Boonruamkaew; Wanida Sukketsiri; Pilaiwanwadee Hutamekalin; Morakot Sroyraya
Journal:  BMC Complement Altern Med       Date:  2018-03-20       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.